Trademark Overview
On Friday, February 2, 2024, a trademark application was filed for NAMSTEYA with the United States Patent and Trademark Office. The USPTO has given the NAMSTEYA trademark a serial number of 98388302. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 1, 2024. This trademark is owned by Emalex Biosciences, Inc.. The NAMSTEYA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome; Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation; Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders